63071-14-7 Usage
General Description
2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)- is a chemical compound with the molecular formula C13H11NO2. 2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)- belongs to the family of Pyridinecarboxaldehydes, specifically the aldehyde class known for its carbonyl group attached to the heterocyclic pyridine ring. 4-(phenylmethoxy)-2-pyridinecarboxaldehyde is known for its unique aromatic properties and is used extensively in organic synthesis, including in pharmaceutical research. It is a light yellow solid and has a faint, sweet scent. This chemical is used as an intermediate in the manufacturing of a wide range of chemicals and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 63071-14-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,0,7 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 63071-14:
(7*6)+(6*3)+(5*0)+(4*7)+(3*1)+(2*1)+(1*4)=97
97 % 10 = 7
So 63071-14-7 is a valid CAS Registry Number.
63071-14-7Relevant articles and documents
Novel heterocyclic derivative capable of being used as SHP2 inhibitor
-
Paragraph 0365, (2019/08/30)
The invention relates to a novel heterocyclic derivative capable of being used as an SHP2 inhibitor, specifically relates to a compound shown by a formula I or pharmaceutically acceptable salts thereof, further relates to a use of the compound shown by the formula I or the pharmaceutically acceptable salts thereof and a pharmaceutical composition thereof in drug preparation, and particularly relates to a use in preparation of drugs for treatment, inhibition or prevention of diseases or discomforts mediated by SHP2 activity.
FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME
-
Paragraph 00185, (2018/03/06)
Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
